NCT00551057

Brief Summary

The purpose of this trial is to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

October 29, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 30, 2007

Completed
4.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

September 17, 2010

Status Verified

October 1, 2007

First QC Date

October 29, 2007

Last Update Submit

September 16, 2010

Conditions

Pancreatic Neoplasms

Interventions

Expression typeBEHAVIORAL

to investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with pancreatic cancer or chronic pancreatitis

You may qualify if:

  • Patients with pancreatic cancer or chronic pancreatitis

You may not qualify if:

  • Patients with alpha 1-antitrypsin deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Zurich Department of Surgery

Zurich, Switzerland

RECRUITING

Biospecimen

Retention: NONE RETAINED

To investigate the expression of different inflammatory proteins in cancer and normal pancreatic tissue

MeSH Terms

Conditions

Pancreatic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Study Officials

  • Marc Schiesser, MD

    UniversitaetsSpital Zuerich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marc Schiesser, MD

CONTACT

+41 (0)44 255 11 11marc.schiesser@usz.ch

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 29, 2007

First Posted

October 30, 2007

Study Start

October 1, 2007

Study Completion

October 1, 2012

Last Updated

September 17, 2010

Record last verified: 2007-10

Locations

CH(1)